Published by Iain Gilbert on 24th July 2024
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics said on Wednesday that total net sales had grown in Q2, driven by "robust" increases in prescriptions and higher net selling prices.
URL: http://www.digitallook.com/dl/news/story/34446608/...